Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jun;22(6):747-748.
doi: 10.1016/S1473-3099(22)00123-2. Epub 2022 Mar 7.

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA

Matthew S Krantz  1 , Elizabeth J Phillips  2
Affiliations
Comment

COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA

Matthew S Krantz et al. Lancet Infect Dis. 2022 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

EJP receives royalties from UpToDate and consulting fees from Janssen, Vertex, Biocryst, and Regeneron. She is co-director of IIID, which holds a patent for HLA-B*57:01 testing for abacavir hypersensitivity. She has a patent pending for Detection of Human Leukocyte Antigen-A*32:01 in connection with Diagnosing Drug Reaction with Eosinophilia and Systemic Symptoms without any financial remuneration and not directly related to the submitted work. Funders played no role in any aspect of this manuscript. MSK declares no competing interests.

Comment on

References

    1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–2615. - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416. - PMC - PubMed
    1. Rosenblum HG, Gee J, Liu R, et al. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe. Lancet Infect Dis. 2022 doi: 10.1016/S1473-3099(22)00054-8. published online March 7. - DOI - PMC - PubMed
    1. Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safetymonitoring in the Vaccine Adverse Event Reporting System (VAERS) Vaccine. 2015;33:4398–4405. - PMC - PubMed
    1. US Centers for Disease Control and Prevention V-safe after vaccination health checker. 2022. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/safety/vsafe.html